Antidepressant-Like Effect of Sodium Butyrate is Associated with an Increase in TET1 and in 5-Hydroxymethylation Levels in the Bdnf Gene

Background:Epigenetic drugs like sodium butyrate (NaB) show antidepressant-like effects in preclinical studies, but the exact molecular mechanisms of the antidepressant effects remain unknown. While research using NaB has mainly focused on its role as a histone deacetylase inhibitor (HDACi), there i...

Full description

Saved in:
Bibliographic Details
Published inThe international journal of neuropsychopharmacology Vol. 18; no. 2; p. pyu032
Main Authors Wei, Ya Bin, Melas, Philippe A., Wegener, Gregers, Mathé, Aleksander A., Lavebratt, Catharina
Format Journal Article
LanguageEnglish
Published England Oxford University Press 01.01.2015
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Background:Epigenetic drugs like sodium butyrate (NaB) show antidepressant-like effects in preclinical studies, but the exact molecular mechanisms of the antidepressant effects remain unknown. While research using NaB has mainly focused on its role as a histone deacetylase inhibitor (HDACi), there is also evidence that NaB affects DNA methylation.Methods:The purpose of this study was to examine NaB’s putative antidepressant-like efficacy in relation to DNA methylation changes in the prefrontal cortex of an established genetic rat model of depression (the Flinders Sensitive Line [FSL]) and its controls (the Flinders Resistant Line).Results:The FSL rats had lower levels of ten-eleven translocation methylcytosine dioxygenase 1 (TET1), which catalyzes the conversion of DNA methylation to hydroxymethylation. As indicated by the behavioral despair test, chronic administration of NaB had antidepressant-like effects in the FSL and was accompanied by increased levels of TET1. The TET1 upregulation was also associated with an increase of hydroxymethylation and a decrease of methylation in brain-derived neurotrophic factor (Bdnf), a gene associated with neurogenesis and synaptic plasticity. These epigenetic changes were associated with a corresponding BDNF overexpression.Conclusions:Our data support the antidepressant efficacy of HDACis and suggest that their epigenetic effects may also include DNA methylation changes that are mediated by demethylation-facilitating enzymes like TET1.
AbstractList Background: Epigenetic drugs like sodium butyrate (NaB) show antidepressant-like effects in preclinical studies, but the exact molecular mechanisms of the antidepressant effects remain unknown. While research using NaB has mainly focused on its role as a histone deacetylase inhibitor (HDACi), there is also evidence that NaB affects DNA methylation. Methods: The purpose of this study was to examine NaB's putative antidepressant-like efficacy in relation to DNA methylation changes in the prefrontal cortex of an established genetic rat model of depression (the Flinders Sensitive Line [FSL]) and its controls (the Flinders Resistant Line). Results: The FSL rats had lower levels of ten-eleven translocation methylcytosine dioxygenase 1 (TET1), which catalyzes the conversion of DNA methylation to hydroxymethylation. As indicated by the behavioral despair test, chronic administration of NaB had antidepressant-like effects in the FSL and was accompanied by increased levels of TET1. The TET1 upregulation was also associated with an increase of hydroxymethylation and a decrease of methylation in brain-derived neurotrophic factor (Bdnf), a gene associated with neurogenesis and synaptic plasticity. These epigenetic changes were associated with a corresponding BDNF overexpression. Conclusions: Our data support the antidepressant efficacy of HDACis and suggest that their epigenetic effects may also include DNA methylation changes that are mediated by demethylation-facilitating enzymes like TET1.
Epigenetic drugs like sodium butyrate (NaB) show antidepressant-like effects in preclinical studies, but the exact molecular mechanisms of the antidepressant effects remain unknown. While research using NaB has mainly focused on its role as a histone deacetylase inhibitor (HDACi), there is also evidence that NaB affects DNA methylation.BACKGROUNDEpigenetic drugs like sodium butyrate (NaB) show antidepressant-like effects in preclinical studies, but the exact molecular mechanisms of the antidepressant effects remain unknown. While research using NaB has mainly focused on its role as a histone deacetylase inhibitor (HDACi), there is also evidence that NaB affects DNA methylation.The purpose of this study was to examine NaB's putative antidepressant-like efficacy in relation to DNA methylation changes in the prefrontal cortex of an established genetic rat model of depression (the Flinders Sensitive Line [FSL]) and its controls (the Flinders Resistant Line).METHODSThe purpose of this study was to examine NaB's putative antidepressant-like efficacy in relation to DNA methylation changes in the prefrontal cortex of an established genetic rat model of depression (the Flinders Sensitive Line [FSL]) and its controls (the Flinders Resistant Line).The FSL rats had lower levels of ten-eleven translocation methylcytosine dioxygenase 1 (TET1), which catalyzes the conversion of DNA methylation to hydroxymethylation. As indicated by the behavioral despair test, chronic administration of NaB had antidepressant-like effects in the FSL and was accompanied by increased levels of TET1. The TET1 upregulation was also associated with an increase of hydroxymethylation and a decrease of methylation in brain-derived neurotrophic factor (Bdnf), a gene associated with neurogenesis and synaptic plasticity. These epigenetic changes were associated with a corresponding BDNF overexpression.RESULTSThe FSL rats had lower levels of ten-eleven translocation methylcytosine dioxygenase 1 (TET1), which catalyzes the conversion of DNA methylation to hydroxymethylation. As indicated by the behavioral despair test, chronic administration of NaB had antidepressant-like effects in the FSL and was accompanied by increased levels of TET1. The TET1 upregulation was also associated with an increase of hydroxymethylation and a decrease of methylation in brain-derived neurotrophic factor (Bdnf), a gene associated with neurogenesis and synaptic plasticity. These epigenetic changes were associated with a corresponding BDNF overexpression.Our data support the antidepressant efficacy of HDACis and suggest that their epigenetic effects may also include DNA methylation changes that are mediated by demethylation-facilitating enzymes like TET1.CONCLUSIONSOur data support the antidepressant efficacy of HDACis and suggest that their epigenetic effects may also include DNA methylation changes that are mediated by demethylation-facilitating enzymes like TET1.
Epigenetic drugs like sodium butyrate (NaB) show antidepressant-like effects in preclinical studies, but the exact molecular mechanisms of the antidepressant effects remain unknown. While research using NaB has mainly focused on its role as a histone deacetylase inhibitor (HDACi), there is also evidence that NaB affects DNA methylation. The purpose of this study was to examine NaB's putative antidepressant-like efficacy in relation to DNA methylation changes in the prefrontal cortex of an established genetic rat model of depression (the Flinders Sensitive Line [FSL]) and its controls (the Flinders Resistant Line). The FSL rats had lower levels of ten-eleven translocation methylcytosine dioxygenase 1 (TET1), which catalyzes the conversion of DNA methylation to hydroxymethylation. As indicated by the behavioral despair test, chronic administration of NaB had antidepressant-like effects in the FSL and was accompanied by increased levels of TET1. The TET1 upregulation was also associated with an increase of hydroxymethylation and a decrease of methylation in brain-derived neurotrophic factor (Bdnf), a gene associated with neurogenesis and synaptic plasticity. These epigenetic changes were associated with a corresponding BDNF overexpression. Our data support the antidepressant efficacy of HDACis and suggest that their epigenetic effects may also include DNA methylation changes that are mediated by demethylation-facilitating enzymes like TET1.
Author Lavebratt, Catharina
Mathé, Aleksander A.
Wei, Ya Bin
Melas, Philippe A.
Wegener, Gregers
Author_xml – sequence: 1
  givenname: Ya Bin
  surname: Wei
  fullname: Wei, Ya Bin
  email: yabin.wei@ki.se
  organization: Department of Molecular Medicine and Surgery, Neurogenetics Unit, Karolinska Institutet, Stockholm, Sweden (Drs Wei, Melas, and Lavebratt); Center for Molecular Medicine, Karolinska Institutet, Stockholm, Sweden (Drs Wei, Melas, and Lavebratt); Translational Neuropsychiatry Unit, Department of Clinical Medicine, Aarhus University, Aarhus, Denmark (Dr Wegener); Centre of Excellence for Pharmaceutical Sciences, North-West University, Potchefstroom, South Africa (Dr Wegener); and Department of Clinical Neuroscience, Section for Psychiatry, Karolinska Institutet, Stockholm, Sweden (Dr Mathé)
– sequence: 2
  givenname: Philippe A.
  surname: Melas
  fullname: Melas, Philippe A.
  organization: Department of Molecular Medicine and Surgery, Neurogenetics Unit, Karolinska Institutet, Stockholm, Sweden (Drs Wei, Melas, and Lavebratt); Center for Molecular Medicine, Karolinska Institutet, Stockholm, Sweden (Drs Wei, Melas, and Lavebratt); Translational Neuropsychiatry Unit, Department of Clinical Medicine, Aarhus University, Aarhus, Denmark (Dr Wegener); Centre of Excellence for Pharmaceutical Sciences, North-West University, Potchefstroom, South Africa (Dr Wegener); and Department of Clinical Neuroscience, Section for Psychiatry, Karolinska Institutet, Stockholm, Sweden (Dr Mathé)
– sequence: 3
  givenname: Gregers
  surname: Wegener
  fullname: Wegener, Gregers
  organization: Department of Molecular Medicine and Surgery, Neurogenetics Unit, Karolinska Institutet, Stockholm, Sweden (Drs Wei, Melas, and Lavebratt); Center for Molecular Medicine, Karolinska Institutet, Stockholm, Sweden (Drs Wei, Melas, and Lavebratt); Translational Neuropsychiatry Unit, Department of Clinical Medicine, Aarhus University, Aarhus, Denmark (Dr Wegener); Centre of Excellence for Pharmaceutical Sciences, North-West University, Potchefstroom, South Africa (Dr Wegener); and Department of Clinical Neuroscience, Section for Psychiatry, Karolinska Institutet, Stockholm, Sweden (Dr Mathé)
– sequence: 4
  givenname: Aleksander A.
  surname: Mathé
  fullname: Mathé, Aleksander A.
  organization: Department of Molecular Medicine and Surgery, Neurogenetics Unit, Karolinska Institutet, Stockholm, Sweden (Drs Wei, Melas, and Lavebratt); Center for Molecular Medicine, Karolinska Institutet, Stockholm, Sweden (Drs Wei, Melas, and Lavebratt); Translational Neuropsychiatry Unit, Department of Clinical Medicine, Aarhus University, Aarhus, Denmark (Dr Wegener); Centre of Excellence for Pharmaceutical Sciences, North-West University, Potchefstroom, South Africa (Dr Wegener); and Department of Clinical Neuroscience, Section for Psychiatry, Karolinska Institutet, Stockholm, Sweden (Dr Mathé)
– sequence: 5
  givenname: Catharina
  surname: Lavebratt
  fullname: Lavebratt, Catharina
  organization: Department of Molecular Medicine and Surgery, Neurogenetics Unit, Karolinska Institutet, Stockholm, Sweden (Drs Wei, Melas, and Lavebratt); Center for Molecular Medicine, Karolinska Institutet, Stockholm, Sweden (Drs Wei, Melas, and Lavebratt); Translational Neuropsychiatry Unit, Department of Clinical Medicine, Aarhus University, Aarhus, Denmark (Dr Wegener); Centre of Excellence for Pharmaceutical Sciences, North-West University, Potchefstroom, South Africa (Dr Wegener); and Department of Clinical Neuroscience, Section for Psychiatry, Karolinska Institutet, Stockholm, Sweden (Dr Mathé)
BackLink https://www.ncbi.nlm.nih.gov/pubmed/25618518$$D View this record in MEDLINE/PubMed
http://kipublications.ki.se/Default.aspx?queryparsed=id:131079937$$DView record from Swedish Publication Index
BookMark eNqNkk1v1DAQhiNURD_gxB1ZQkJIKNSTxIlzqbStlrbSShxYzpaTTFhvEzvYTkv-AT8bb7NFtEKIk8fzPvNqxp7j6EAbjVH0GuhHoGV6qrZ6OB2mkabJs-gIsryMGQAc3McQQ8aKw-jYuS2lScbS_EV0mLAcOAN-FP1caK8aHCw6J7WPV-oGybJtsfbEtOSLadTYk_PRT1Z6JMqRhXOmVuHSkDvlN0Rqcq1ri9IFWZP1cg0h1-xiFl9NjTU_ph79ZuqkV0aTFd5i53ay3yA5b3RLLlHjy-h5KzuHr_bnSfT103J9cRWvPl9eXyxWcc04-BhYzlLAXJYZFm1W1SVvZClLyjk20BZZJfMwfMIZR-QMZVoWVcppARSqJGvTkyiefd0dDmMlBqt6aSdhpBL71E2IUDDIIU0CfzbzQemxqVF7K7tHZY8VrTbim7kVWZpzXkIweL83sOb7iM6LXrkau05qNKMTUOSsLFhJ_wPNWZJRSjkN6Nsn6NaMVoeXEykUFLLQOgvUmz-b_931w_8HAGagtsY5i62olb__pzCL6gRQsdsxsdsxMe9YqPnwpObB9u_0u5k24_BP8Bc9r-JR
CitedBy_id crossref_primary_10_3389_fcimb_2020_567268
crossref_primary_10_3389_fnins_2023_1151478
crossref_primary_10_1093_cercor_bhx095
crossref_primary_10_3389_fpsyt_2018_00454
crossref_primary_10_1016_j_neulet_2016_02_009
crossref_primary_10_1093_ijnp_pyw069
crossref_primary_10_1016_j_jad_2019_02_009
crossref_primary_10_3390_ijms22062973
crossref_primary_10_3233_JAD_215290
crossref_primary_10_3390_microorganisms12102006
crossref_primary_10_1097_MOG_0000000000000244
crossref_primary_10_3390_ijms26031082
crossref_primary_10_3389_fgene_2023_1158954
crossref_primary_10_3389_fphar_2021_712531
crossref_primary_10_1016_j_neuropharm_2021_108782
crossref_primary_10_1016_j_ijdevneu_2017_03_007
crossref_primary_10_3390_molecules28073213
crossref_primary_10_2174_1570159X20666220201084536
crossref_primary_10_1016_j_gtc_2019_04_006
crossref_primary_10_1021_acsomega_3c05846
crossref_primary_10_33619_2414_2948_61_15
crossref_primary_10_1096_fj_201601340RR
crossref_primary_10_2217_epi_2017_0077
crossref_primary_10_3389_fnbeh_2017_00041
crossref_primary_10_1007_s10571_021_01108_0
crossref_primary_10_3390_ijms24076617
crossref_primary_10_3389_fnins_2019_01361
crossref_primary_10_1038_s41380_023_02099_8
crossref_primary_10_1016_j_biocel_2015_11_002
crossref_primary_10_1016_j_pnpbp_2023_110861
crossref_primary_10_1038_s41598_024_80228_1
crossref_primary_10_1016_j_jad_2022_08_012
crossref_primary_10_1016_j_micres_2023_127440
crossref_primary_10_3390_biomedicines9070704
crossref_primary_10_3389_fnut_2021_750333
crossref_primary_10_3389_fpsyt_2021_641491
crossref_primary_10_1139_gen_2020_0136
crossref_primary_10_1016_j_ecoenv_2021_112108
crossref_primary_10_3390_microorganisms11051334
crossref_primary_10_4235_agmr_19_0014
crossref_primary_10_1002_prp2_70058
crossref_primary_10_1080_10408398_2022_2137776
crossref_primary_10_1126_scisignal_aac7695
crossref_primary_10_3389_fnins_2023_1134080
crossref_primary_10_1016_j_jbiotec_2016_11_020
crossref_primary_10_5005_jp_journals_10006_2411
crossref_primary_10_3390_nu14193946
crossref_primary_10_1016_j_neuro_2017_06_007
crossref_primary_10_1016_j_biopha_2024_116420
crossref_primary_10_3346_jkms_2023_38_e120
crossref_primary_10_3389_fnut_2022_867150
crossref_primary_10_3390_ijms24043543
crossref_primary_10_1016_j_biopha_2022_113870
crossref_primary_10_1038_s41430_023_01270_2
crossref_primary_10_7717_peerj_10125
crossref_primary_10_1007_s00213_018_4947_z
crossref_primary_10_3389_fpsyt_2019_00808
crossref_primary_10_3389_fnins_2022_1029495
crossref_primary_10_1016_j_ygeno_2024_110959
crossref_primary_10_1007_s12035_023_03697_x
crossref_primary_10_1186_s13073_019_0621_2
crossref_primary_10_3389_fmicb_2024_1456793
crossref_primary_10_1186_s13024_022_00548_6
crossref_primary_10_1080_10408398_2022_2051164
crossref_primary_10_3389_fnins_2018_00155
crossref_primary_10_3390_nutraceuticals2020007
crossref_primary_10_1016_j_jpsychires_2020_07_018
crossref_primary_10_1016_j_pharmthera_2022_108279
crossref_primary_10_1111_febs_17200
crossref_primary_10_3390_foods14050870
crossref_primary_10_3389_fphys_2024_1338544
crossref_primary_10_3390_ijms25179489
crossref_primary_10_1038_s41467_021_23281_y
crossref_primary_10_1111_apm_13257
crossref_primary_10_1136_gpsych_2023_101374
crossref_primary_10_3389_fendo_2020_00025
crossref_primary_10_1016_j_envres_2024_118441
crossref_primary_10_1002_advs_201900752
crossref_primary_10_1016_j_psychres_2021_113987
crossref_primary_10_3389_fimmu_2018_01832
crossref_primary_10_1038_srep37411
crossref_primary_10_1016_j_isci_2023_106627
crossref_primary_10_1007_s40263_016_0370_3
crossref_primary_10_1177_0706743719874168
crossref_primary_10_3390_nu14142982
crossref_primary_10_1016_j_brainres_2024_149125
crossref_primary_10_1016_j_jad_2022_12_035
crossref_primary_10_1002_ddr_21340
crossref_primary_10_1007_s12035_022_02917_0
crossref_primary_10_1186_s12991_023_00469_8
Cites_doi 10.1017/S1461145711000940
10.1001/archpsyc.1994.03950010008002
10.1371/journal.pone.0014524
10.1016/j.biopsych.2006.06.036
10.1126/science.1169786
10.1038/sj.mp.4001637
10.1038/tp.2013.31
10.1016/S0021-9258(17)35855-6
10.1093/carcin/bgl167
10.1002/jnr.21139
10.1016/j.cell.2013.12.020
10.1523/JNEUROSCI.1786-08.2008
10.2174/138161212803523590
10.1038/mp.2010.131
10.1073/pnas.1216100110
10.1016/j.bbr.2012.01.050
10.1016/j.janxdis.2008.03.013
10.1038/nrn2132
10.1038/mp.2012.10
10.1016/0092-8674(78)90306-9
10.1073/pnas.191352298
10.5498/wjp.v2.i3.49
10.1074/jbc.M303740200
10.1126/science.1090842
10.1038/nrm2950
10.1016/S0028-3908(03)00198-9
10.1016/j.neuron.2013.08.032
10.1097/CAD.0b013e32835739dd
10.1016/j.cell.2012.11.022
10.1016/S0006-3223(03)00231-2
10.3109/15622975.2011.585663
10.1016/j.neuron.2010.12.023
10.1016/0092-8674(78)90305-7
10.1124/mol.109.061333
10.1186/gb-2007-8-2-r19
10.1523/JNEUROSCI.5731-07.2008
10.1093/nar/29.17.3603
10.1523/JNEUROSCI.1758-09.2009
10.1177/0269881110393049
10.1101/gad.12.5.599
10.1016/j.neuroscience.2005.12.058
10.1126/science.1170116
10.1523/JNEUROSCI.3136-11.2012
10.1006/excr.1994.1107
10.1016/j.bbr.2008.08.039
10.1101/lm.500907
10.1371/journal.pone.0040262
10.1038/nn1944
10.1038/nn.2207
10.1124/pr.111.005397
10.1016/j.neubiorev.2005.03.015
10.1093/hmg/8.12.2317
10.1016/0167-4781(90)90124-K
10.1371/journal.pone.0058473
10.1016/j.neuron.2005.09.023
10.1038/nn1659
10.1073/pnas.1114863108
10.1111/j.1471-4159.1966.tb09873.x
10.1111/j.1476-5381.2011.01489.x
10.1038/nature12750
10.1038/mp.2011.107
10.1016/j.cell.2011.03.022
10.1111/j.1365-2125.2011.04100.x
ContentType Journal Article
Copyright The Author 2015. Published by Oxford University Press on behalf of CINP. 2015
The Author 2015. Published by Oxford University Press on behalf of CINP.
The Author 2015. Published by Oxford University Press on behalf of CINP. This work is published under http://creativecommons.org/licenses/by-nc/4.0 (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Copyright_xml – notice: The Author 2015. Published by Oxford University Press on behalf of CINP. 2015
– notice: The Author 2015. Published by Oxford University Press on behalf of CINP.
– notice: The Author 2015. Published by Oxford University Press on behalf of CINP. This work is published under http://creativecommons.org/licenses/by-nc/4.0 (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
DBID TOX
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7X7
7XB
88E
88G
8AO
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
FYUFA
GHDGH
GNUQQ
K9.
M0S
M1P
M2M
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
PRINS
PSYQQ
Q9U
7X8
7TK
5PM
ADTPV
AOWAS
D8T
ZZAVC
DOI 10.1093/ijnp/pyu032
DatabaseName Oxford Journals Open Access Collection (WRLC)
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Psychology Database (Alumni)
ProQuest Pharma Collection
ProQuest Hospital Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
ProQuest Central
ProQuest One
ProQuest Central Korea
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
ProQuest Health & Medical Complete (Alumni)
ProQuest Health & Medical Collection
Medical Database
Psychology Database
ProQuest Central Premium
ProQuest One Academic (New)
Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
ProQuest One Psychology
ProQuest Central Basic
MEDLINE - Academic
Neurosciences Abstracts
PubMed Central (Full Participant titles)
SwePub
SwePub Articles
SWEPUB Freely available online
SwePub Articles full text
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Publicly Available Content Database
ProQuest One Psychology
ProQuest Central Student
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Pharma Collection
ProQuest Central China
ProQuest Central
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Health & Medical Research Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest Central Basic
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Psychology Journals (Alumni)
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest Psychology Journals
ProQuest One Academic UKI Edition
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
Neurosciences Abstracts
DatabaseTitleList Neurosciences Abstracts
Publicly Available Content Database
MEDLINE - Academic
MEDLINE

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: TOX
  name: Oxford Journals Open Access Collection (WRLC)
  url: https://academic.oup.com/journals/
  sourceTypes: Publisher
– sequence: 4
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Pharmacy, Therapeutics, & Pharmacology
EISSN 1469-5111
EndPage pyu032
ExternalDocumentID oai_swepub_ki_se_516132
PMC4368891
25618518
10_1093_ijnp_pyu032
10.1093/ijnp/pyu032
Genre Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
-E.
.FH
0E1
0R~
123
29J
4.4
5VS
74X
74Y
7~V
8R4
8R5
AAFWJ
AAMVS
AAOGV
AAPPN
AAPXW
AAVAP
ABEJV
ABGNP
ABITZ
ABIVO
ABKKG
ABPTD
ABQLI
ABVKB
ABXVV
ACGFS
ACIMK
ADBBV
ADHZD
ADRAZ
AEMTW
AENEX
AENZO
AFFVI
AFULF
AFUTZ
AHMBA
AJ7
ALIPV
ALMA_UNASSIGNED_HOLDINGS
ALUQC
AMNDL
AOIJS
ARABE
AVWKF
BAWUL
BAYMD
BCNDV
BTTYL
C0O
CIDKT
CS3
DC4
DIK
DU5
EBS
EJD
EMOBN
GROUPED_DOAJ
H13
HG-
HST
HYE
HZ~
I.6
I~P
J36
J38
J3A
KQ8
KSI
L98
M-V
M48
ML0
M~E
O9-
OAWHX
OJQWA
OK1
P2P
PEELM
Q2X
RHF
ROL
ROX
RPM
RR0
S6-
S70
TJX
TOX
TUQ
UU6
WQ3
WXU
WYP
7X7
88E
8AO
8FI
8FJ
AAYXX
ABUWG
AFKRA
AFPKN
AZQEC
BENPR
CCPQU
CITATION
DWQXO
FYUFA
GNUQQ
HMCUK
M1P
M2M
PHGZM
PHGZT
PIMPY
PSQYO
PSYQQ
UKHRP
3V.
BPHCQ
BVXVI
CGR
CUY
CVF
ECM
EIF
NPM
PQQKQ
PROAC
7XB
8FK
K9.
PJZUB
PKEHL
PPXIY
PQEST
PQUKI
PRINS
Q9U
7X8
7TK
5PM
0VX
53G
ADTPV
AOWAS
CAG
COF
D8T
IAO
IHR
ITC
PUEGO
ZZAVC
ID FETCH-LOGICAL-c581t-156531e6a94e7f4bc98da9a9088ed1f74ba61112858ee85ea397b3807101b24f3
IEDL.DBID 7X7
ISSN 1461-1457
1469-5111
IngestDate Mon Sep 01 03:33:37 EDT 2025
Thu Aug 21 18:30:31 EDT 2025
Fri Jul 11 06:17:42 EDT 2025
Fri Jul 11 12:22:32 EDT 2025
Fri Jul 25 21:46:26 EDT 2025
Wed Feb 19 01:53:31 EST 2025
Tue Jul 01 03:53:12 EDT 2025
Thu Apr 24 22:59:54 EDT 2025
Tue Feb 04 08:58:38 EST 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 2
Keywords DNA methylation
TET1
depression
epigenetics
Language English
License This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
The Author 2015. Published by Oxford University Press on behalf of CINP.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c581t-156531e6a94e7f4bc98da9a9088ed1f74ba61112858ee85ea397b3807101b24f3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
OpenAccessLink https://www.proquest.com/docview/3170143235?pq-origsite=%requestingapplication%
PMID 25618518
PQID 3170143235
PQPubID 43629
PageCount 10
ParticipantIDs swepub_primary_oai_swepub_ki_se_516132
pubmedcentral_primary_oai_pubmedcentral_nih_gov_4368891
proquest_miscellaneous_1765975901
proquest_miscellaneous_1652400080
proquest_journals_3170143235
pubmed_primary_25618518
crossref_citationtrail_10_1093_ijnp_pyu032
crossref_primary_10_1093_ijnp_pyu032
oup_primary_10_1093_ijnp_pyu032
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2015-01-01
PublicationDateYYYYMMDD 2015-01-01
PublicationDate_xml – month: 01
  year: 2015
  text: 2015-01-01
  day: 01
PublicationDecade 2010
PublicationPlace England
PublicationPlace_xml – name: England
– name: Oxford
PublicationTitle The international journal of neuropsychopharmacology
PublicationTitleAlternate Int J Neuropsychopharmacol
PublicationYear 2015
Publisher Oxford University Press
Publisher_xml – name: Oxford University Press
References Candido (9_4590366) 1978; 14
(43_49653096) 2013; 3
(46_22675046) 2007; 28
Fischer (20_41962185) 2012; 230
Aid (1_23588426) 2007; 85
(31_47715364) 2013; 79
Yamawaki (73_40493093) 2012; 13
(11_49653094) 2012; 17
Benjamin (3_11295946) 2001; 29
Cosgrove (12_9170839) 1990; 1087
Boffa (5_14703568) 1994; 211
Boulle (6_40716573) 2012; 17
(24_35995229) 2010; 77
Martinowich (41_17884507) 2003; 302
(66_34597445) 2009; 324
(23_47494005) 2014; 156
Shin (63_41777870) 2012; 40
Overstreet (50_18888825) 2005; 29
Sealy (61_4590367) 1978; 14
Pandey (51_30723630) 2008; 28
(29_47539373) 2012; 4
(47_45122782) 2013; 110
Dias (16_17758438) 2003; 45
(70_48325913) 2011; 69
(10_37686686) 1999; 8
(27_39012577) 2011; 25
Guo (26_39742981) 2011; 145
(67_48234658) 2013; 8
Angelucci (2_18766994) 2005; 10
Wu (72_37815447) 2010; 11
(15_19562362) 2003; 278
Schroeder (60_28911220) 2007; 62
Biard (4_9982538) 1992; 52
Porsolt (55_4419438) 1977; 229
Dwivedi (17_22090726) 2006; 139
Sales (58_39966655) 2011; 164
West (71_11334367) 2001; 98
Lubin (40_32160629) 2008; 28
Overstreet (49_44870054) 2013; 65
Robinson (57_31365812) 2009; 23
Covington (13_35573231) 2009; 29
Tsankova (68_21847439) 2006; 9
de Haan (14_13689453) 1986; 46
Ressler (56_29320008) 2007; 10
Struhl (64_5925119) 1998; 12
Fava (19_17593975) 2003; 53
Parker (52_13749657) 1986; 261
(62_49653097) 2012; 2
Lu (39_43033534) 2012; 7
Glowinski (21_7173440) 1966; 13
Oldham (48_32196907) 2008; 11
Tsankova (69_28473872) 2007; 8
(42_49653095) 2012; 15
(30_45482195) 2011; 5
Menke (45_42825189) 2012; 18
Eriksson (18_39064815) 2012; 17
(22_46381271) 2013; 18
Kessler (32_14665707) 1994; 51
Hellemans (28_23645204) 2007; 8
(65_49653098) 2013; 7
Gu (25_43367613) 2012; 23
Bredy (7_28300649) 2007; 14
Zhu (74_32035409) 2009; 196
Kumar (36_19495778) 2005; 48
(37_42560642) 2011; 3
(44_45706308) 2012; 151
Peedicayil (53_41090780) 2012; 73
(34_47362447) 2013; 502
(35_34597441) 2009; 324
(38_41040395) 2011; 108
Brenet (8_39107615) 2011; 6
SARKAR (59_40445373) 2011; 31
Ponomarev (54_41601956) 2012; 32
19372391 - Science. 2009 May 15;324(5929):930-5
23319547 - Pharmacol Rev. 2013 Jan;65(1):143-55
23052292 - Sci Transl Med. 2012 Oct 10;4(155):155ps19
17012225 - Carcinogenesis. 2007 Mar;28(3):560-71
16242410 - Neuron. 2005 Oct 20;48(2):303-14
24452011 - Neuropharmacology. 2014 May;80:115-32
22768266 - PLoS One. 2012;7(6):e40262
8143791 - Exp Cell Res. 1994 Apr;211(2):420-3
14593184 - Science. 2003 Oct 31;302(5646):890-3
667927 - Cell. 1978 May;14(1):105-13
21585346 - Br J Pharmacol. 2011 Nov;164(6):1711-21
21267076 - PLoS One. 2011;6(1):e14524
22321459 - Behav Brain Res. 2012 Apr 21;230(1):85-91
23908608 - Front Integr Neurosci. 2013 Jul 29;7:55
15925699 - Neurosci Biobehav Rev. 2005;29(4-5):739-59
21496894 - Cell. 2011 Apr 29;145(3):423-34
23382250 - Proc Natl Acad Sci U S A. 2013 Mar 19;110(12):4804-9
16501568 - Nat Neurosci. 2006 Apr;9(4):519-25
24050399 - Neuron. 2013 Sep 18;79(6):1086-93
1382840 - Cancer Res. 1992 Oct 1;52(19):5213-8
23260135 - Cell. 2012 Dec 21;151(7):1417-30
22049069 - Sci Transl Med. 2011 Nov 2;3(107):107ra109
19917878 - Mol Pharmacol. 2010 Feb;77(2):126-35
9499396 - Genes Dev. 1998 Mar 1;12(5):599-606
17453016 - Nat Rev Neurosci. 2007 May;8(5):355-67
667928 - Cell. 1978 May;14(1):115-21
18817816 - Behav Brain Res. 2009 Jan 23;196(2):200-6
16945350 - Biol Psychiatry. 2007 Jul 1;62(1):55-64
2419322 - J Biol Chem. 1986 Feb 25;261(6):2786-90
11572963 - Proc Natl Acad Sci U S A. 2001 Sep 25;98(20):11024-31
23652932 - Transl Psychiatry. 2013;3:e255
25888486 - Int J Neuropsychopharmacol. 2015 Apr;18(6). pii: pyv026. doi: 10.1093/ijnp/pyv026
21868513 - Anticancer Res. 2011 Sep;31(9):2723-32
21894152 - Mol Psychiatry. 2012 Jun;17(6):584-96
22371047 - Mol Psychiatry. 2013 May;18(5):582-94
16500030 - Neuroscience. 2006;139(3):1017-29
23469282 - PLoS One. 2013;8(3):e58473
5950056 - J Neurochem. 1966 Aug;13(8):655-69
17522015 - Learn Mem. 2007 Apr;14(4):268-76
18849986 - Nat Neurosci. 2008 Nov;11(11):1271-82
19372393 - Science. 2009 May 15;324(5929):929-30
10545613 - Hum Mol Genet. 1999 Nov;8(12):2317-23
8279933 - Arch Gen Psychiatry. 1994 Jan;51(1):8-19
22302827 - J Neurosci. 2012 Feb 1;32(5):1884-97
22023150 - Br J Clin Pharmacol. 2012 Feb;73(2):309-10
22863973 - Anticancer Drugs. 2012 Nov;23(10):1054-66
22339643 - Expert Opin Emerg Drugs. 2012 Mar;17(1):105-26
15655562 - Mol Psychiatry. 2005 Apr;10(4):345-52
21242991 - Mol Psychiatry. 2012 Feb;17(2):173-84
21262472 - Neuron. 2011 Jan 27;69(2):359-72
24153300 - Nature. 2013 Oct 24;502(7472):472-9
12706951 - Biol Psychiatry. 2003 Apr 15;53(8):649-59
17291332 - Genome Biol. 2007;8(2):R19
17726478 - Nat Neurosci. 2007 Sep;10(9):1116-24
21682946 - Int J Neuropsychopharmacol. 2012 Jun;15(5):669-79
24175168 - World J Psychiatry. 2012 Jun 22;2(3):49-57
21812623 - World J Biol Psychiatry. 2012 Sep;13(6):458-67
2416432 - Cancer Res. 1986 Feb;46(2):713-6
18571370 - J Anxiety Disord. 2009 Jan;23(1):38-45
21262856 - J Psychopharmacol. 2011 Oct;25(10):1378-87
18385331 - J Neurosci. 2008 Apr 2;28(14):3729-37
22681167 - Curr Pharm Des. 2012;18(36):5879-89
17149751 - J Neurosci Res. 2007 Feb 15;85(3):525-35
22025706 - Proc Natl Acad Sci U S A. 2011 Nov 1;108(44):18108-13
12907316 - Neuropharmacology. 2003 Sep;45(4):553-63
11522830 - Nucleic Acids Res. 2001 Sep 1;29(17):3603-10
18923034 - J Neurosci. 2008 Oct 15;28(42):10576-86
1698097 - Biochim Biophys Acta. 1990 Sep 10;1087(1):80-6
20683471 - Nat Rev Mol Cell Biol. 2010 Sep;11(9):607-20
24439381 - Cell. 2014 Jan 16;156(1-2):261-76
19759294 - J Neurosci. 2009 Sep 16;29(37):11451-60
12748177 - J Biol Chem. 2003 Jul 25;278(30):27586-92
22246241 - Int J Oncol. 2012 May;40(5):1533-42
596982 - Arch Int Pharmacodyn Ther. 1977 Oct;229(2):327-36
22784618 - BMC Syst Biol. 2011;5 Suppl 3:S12
References_xml – volume: 46
  start-page: 713
  issn: 0008-5472
  issue: 2
  year: 1986
  ident: 14_13689453
  publication-title: Cancer Research
– volume: 15
  start-page: 669
  year: 2012
  ident: 42_49653095
  publication-title: INT J NEUROPSYCHOP
  doi: 10.1017/S1461145711000940
– volume: 51
  start-page: 8
  issn: 0003-990X
  issue: 1
  year: 1994
  ident: 32_14665707
  publication-title: Archives of General Psychiatry
  doi: 10.1001/archpsyc.1994.03950010008002
– volume: 52
  start-page: 5213
  issn: 0008-5472
  issue: 19
  year: 1992
  ident: 4_9982538
  publication-title: Cancer Research
– volume: 6
  start-page: e14524
  issn: 1932-6203
  issue: 1
  year: 2011
  ident: 8_39107615
  doi: 10.1371/journal.pone.0014524
– volume: 62
  start-page: 55
  issn: 0006-3223
  issue: 1
  year: 2007
  ident: 60_28911220
  publication-title: Biological psychiatry
  doi: 10.1016/j.biopsych.2006.06.036
– volume: 324
  start-page: 929
  issn: 0036-8075
  issue: 5929
  year: 2009
  ident: 35_34597441
  publication-title: Science
  doi: 10.1126/science.1169786
– volume: 10
  start-page: 345
  issn: 1359-4184
  issue: 4
  year: 2005
  ident: 2_18766994
  publication-title: Molecular psychiatry
  doi: 10.1038/sj.mp.4001637
– volume: 3
  start-page: 255e
  year: 2013
  ident: 43_49653096
  publication-title: TRANSL PSYCHIATRY
  doi: 10.1038/tp.2013.31
– volume: 261
  start-page: 2786
  issn: 0021-9258
  issue: 6
  year: 1986
  ident: 52_13749657
  publication-title: Journal of Biological Chemistry
  doi: 10.1016/S0021-9258(17)35855-6
– volume: 28
  start-page: 560
  issn: 0143-3334
  issue: 3
  year: 2007
  ident: 46_22675046
  publication-title: Carcinogenesis
  doi: 10.1093/carcin/bgl167
– volume: 85
  start-page: 525
  issn: 0360-4012
  issue: 3
  year: 2007
  ident: 1_23588426
  publication-title: Journal of neuroscience research
  doi: 10.1002/jnr.21139
– volume: 156
  start-page: 261
  issn: 0092-8674
  year: 2014
  ident: 23_47494005
  publication-title: Cell
  doi: 10.1016/j.cell.2013.12.020
– volume: 28
  start-page: 10576
  issn: 0270-6474
  issue: 42
  year: 2008
  ident: 40_32160629
  publication-title: Journal of Neuroscience
  doi: 10.1523/JNEUROSCI.1786-08.2008
– volume: 18
  start-page: 5879
  issn: 1381-6128
  year: 2012
  ident: 45_42825189
  publication-title: Current pharmaceutical design
  doi: 10.2174/138161212803523590
– volume: 17
  start-page: 173
  issn: 1359-4184
  issue: 2
  year: 2012
  ident: 18_39064815
  publication-title: Molecular psychiatry
  doi: 10.1038/mp.2010.131
– volume: 110
  start-page: 4804
  issn: 0027-8424
  issue: 12
  year: 2013
  ident: 47_45122782
  publication-title: PNAS
  doi: 10.1073/pnas.1216100110
– volume: 5
  start-page: S12
  issn: 1752-0509
  year: 2011
  ident: 30_45482195
– volume: 230
  start-page: 85
  issn: 0166-4328
  issue: 1
  year: 2012
  ident: 20_41962185
  publication-title: Behavioural brain research
  doi: 10.1016/j.bbr.2012.01.050
– volume: 23
  start-page: 38
  issn: 0887-6185
  issue: 1
  year: 2009
  ident: 57_31365812
  publication-title: Journal of anxiety disorders
  doi: 10.1016/j.janxdis.2008.03.013
– volume: 8
  start-page: 355
  issn: 1471-003X
  issue: 5
  year: 2007
  ident: 69_28473872
  publication-title: Nature reviews. Neuroscience
  doi: 10.1038/nrn2132
– volume: 18
  start-page: 582
  issn: 1359-4184
  year: 2013
  ident: 22_46381271
  publication-title: Molecular psychiatry
  doi: 10.1038/mp.2012.10
– volume: 229
  start-page: 327
  issn: 0003-9780
  issue: 2
  year: 1977
  ident: 55_4419438
  publication-title: Archives internationales de pharmacodynamie et de th  rapie
– volume: 14
  start-page: 115
  issn: 0092-8674
  issue: 1
  year: 1978
  ident: 61_4590367
  publication-title: Cell
  doi: 10.1016/0092-8674(78)90306-9
– volume: 40
  start-page: 1533
  issn: 1019-6439
  issue: 5
  year: 2012
  ident: 63_41777870
  publication-title: International journal of oncology
– volume: 31
  start-page: 2723
  issn: 0250-7005
  issue: 9
  year: 2011
  ident: 59_40445373
  publication-title: Anticancer Research
– volume: 98
  start-page: 11024
  issn: 0027-8424
  issue: 20
  year: 2001
  ident: 71_11334367
  publication-title: PNAS
  doi: 10.1073/pnas.191352298
– volume: 2
  start-page: 49
  year: 2012
  ident: 62_49653097
  publication-title: WORLD J PSYCHIATRY
  doi: 10.5498/wjp.v2.i3.49
– volume: 278
  start-page: 27586
  issn: 0021-9258
  issue: 30
  year: 2003
  ident: 15_19562362
  publication-title: Journal of Biological Chemistry
  doi: 10.1074/jbc.M303740200
– volume: 302
  start-page: 890
  issn: 0036-8075
  issue: 5646
  year: 2003
  ident: 41_17884507
  publication-title: Science
  doi: 10.1126/science.1090842
– volume: 11
  start-page: 607
  issn: 1471-0072
  issue: 9
  year: 2010
  ident: 72_37815447
  publication-title: Nature reviews. Molecular cell biology
  doi: 10.1038/nrm2950
– volume: 45
  start-page: 553
  issn: 0028-3908
  issue: 4
  year: 2003
  ident: 16_17758438
  publication-title: Neuropharmacology
  doi: 10.1016/S0028-3908(03)00198-9
– volume: 79
  start-page: 1086
  issn: 0896-6273
  year: 2013
  ident: 31_47715364
  publication-title: Neuron
  doi: 10.1016/j.neuron.2013.08.032
– volume: 23
  start-page: 1054
  issn: 0959-4973
  issue: 10
  year: 2012
  ident: 25_43367613
  publication-title: Anti-cancer drugs
  doi: 10.1097/CAD.0b013e32835739dd
– volume: 151
  start-page: 1417
  issn: 0092-8674
  year: 2012
  ident: 44_45706308
  publication-title: Cell
  doi: 10.1016/j.cell.2012.11.022
– volume: 53
  start-page: 649
  issn: 0006-3223
  issue: 8
  year: 2003
  ident: 19_17593975
  publication-title: Biological psychiatry
  doi: 10.1016/S0006-3223(03)00231-2
– volume: 7
  start-page: 55
  issn: 1662-5145
  year: 2013
  ident: 65_49653098
– volume: 13
  start-page: 458
  issn: 1562-2975
  issue: 6
  year: 2012
  ident: 73_40493093
  publication-title: The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry
  doi: 10.3109/15622975.2011.585663
– volume: 69
  start-page: 359
  issn: 0896-6273
  year: 2011
  ident: 70_48325913
  publication-title: Neuron
  doi: 10.1016/j.neuron.2010.12.023
– volume: 14
  start-page: 105
  issn: 0092-8674
  issue: 1
  year: 1978
  ident: 9_4590366
  publication-title: Cell
  doi: 10.1016/0092-8674(78)90305-7
– volume: 77
  start-page: 126
  issn: 0026-895X
  issue: 2
  year: 2010
  ident: 24_35995229
  publication-title: Molecular Pharmacology
  doi: 10.1124/mol.109.061333
– volume: 8
  start-page: R19
  issn: 1465-6906
  issue: 2
  year: 2007
  ident: 28_23645204
  publication-title: Genome biology
  doi: 10.1186/gb-2007-8-2-r19
– volume: 28
  start-page: 3729
  issn: 0270-6474
  issue: 14
  year: 2008
  ident: 51_30723630
  publication-title: Journal of Neuroscience
  doi: 10.1523/JNEUROSCI.5731-07.2008
– volume: 29
  start-page: 3603
  issn: 0305-1048
  issue: 17
  year: 2001
  ident: 3_11295946
  publication-title: Nucleic Acids Research
  doi: 10.1093/nar/29.17.3603
– volume: 29
  start-page: 11451
  issn: 0270-6474
  issue: 37
  year: 2009
  ident: 13_35573231
  publication-title: Journal of Neuroscience
  doi: 10.1523/JNEUROSCI.1758-09.2009
– volume: 25
  start-page: 1378
  issn: 0269-8811
  issue: 10
  year: 2011
  ident: 27_39012577
  publication-title: Journal of Psychopharmacology
  doi: 10.1177/0269881110393049
– volume: 12
  start-page: 599
  issn: 0890-9369
  issue: 5
  year: 1998
  ident: 64_5925119
  publication-title: Genes & Development
  doi: 10.1101/gad.12.5.599
– volume: 139
  start-page: 1017
  issn: 0306-4522
  issue: 3
  year: 2006
  ident: 17_22090726
  publication-title: Neuroscience
  doi: 10.1016/j.neuroscience.2005.12.058
– volume: 324
  start-page: 930
  issn: 0036-8075
  issue: 5929
  year: 2009
  ident: 66_34597445
  publication-title: Science
  doi: 10.1126/science.1170116
– volume: 32
  start-page: 1884
  issn: 0270-6474
  issue: 5
  year: 2012
  ident: 54_41601956
  publication-title: Journal of Neuroscience
  doi: 10.1523/JNEUROSCI.3136-11.2012
– volume: 211
  start-page: 420
  issn: 0014-4827
  issue: 2
  year: 1994
  ident: 5_14703568
  publication-title: Experimental cell research
  doi: 10.1006/excr.1994.1107
– volume: 196
  start-page: 200
  issn: 0166-4328
  issue: 2
  year: 2009
  ident: 74_32035409
  publication-title: Behavioural brain research
  doi: 10.1016/j.bbr.2008.08.039
– volume: 14
  start-page: 268
  issn: 1072-0502
  issue: 4
  year: 2007
  ident: 7_28300649
  publication-title: Learning & Memory
  doi: 10.1101/lm.500907
– volume: 7
  start-page: e40262
  issn: 1932-6203
  issue: 6
  year: 2012
  ident: 39_43033534
  doi: 10.1371/journal.pone.0040262
– volume: 17
  start-page: 105
  year: 2012
  ident: 11_49653094
  publication-title: EOMD
– volume: 10
  start-page: 1116
  issn: 1097-6256
  issue: 9
  year: 2007
  ident: 56_29320008
  publication-title: Nature neuroscience
  doi: 10.1038/nn1944
– volume: 11
  start-page: 1271
  issn: 1097-6256
  issue: 11
  year: 2008
  ident: 48_32196907
  publication-title: Nature neuroscience
  doi: 10.1038/nn.2207
– volume: 65
  start-page: 143
  issn: 0031-6997
  issue: 1
  year: 2013
  ident: 49_44870054
  publication-title: Pharmacological Reviews
  doi: 10.1124/pr.111.005397
– volume: 29
  start-page: 739
  issn: 0149-7634
  issue: 4-5
  year: 2005
  ident: 50_18888825
  publication-title: Neuroscience and biobehavioral reviews
  doi: 10.1016/j.neubiorev.2005.03.015
– volume: 8
  start-page: 2317
  issn: 0964-6906
  issue: 12
  year: 1999
  ident: 10_37686686
  publication-title: Human Molecular Genetics
  doi: 10.1093/hmg/8.12.2317
– volume: 1087
  start-page: 80
  issn: 0006-3002
  issue: 1
  year: 1990
  ident: 12_9170839
  publication-title: Biochimica et Biophysica Acta. Protein Structure and Molecular Enzymology
  doi: 10.1016/0167-4781(90)90124-K
– volume: 8
  start-page: e58473
  issn: 1932-6203
  year: 2013
  ident: 67_48234658
  doi: 10.1371/journal.pone.0058473
– volume: 4
  start-page: 155
  issn: 1946-6234
  year: 2012
  ident: 29_47539373
  publication-title: Science Translational Medicine
– volume: 48
  start-page: 303
  issn: 0896-6273
  issue: 2
  year: 2005
  ident: 36_19495778
  publication-title: Neuron
  doi: 10.1016/j.neuron.2005.09.023
– volume: 9
  start-page: 519
  issn: 1097-6256
  issue: 4
  year: 2006
  ident: 68_21847439
  publication-title: Nature neuroscience
  doi: 10.1038/nn1659
– volume: 108
  start-page: 18108
  issn: 0027-8424
  issue: 44
  year: 2011
  ident: 38_41040395
  publication-title: PNAS
  doi: 10.1073/pnas.1114863108
– volume: 13
  start-page: 655
  issn: 0022-3042
  issue: 8
  year: 1966
  ident: 21_7173440
  publication-title: Journal of neurochemistry
  doi: 10.1111/j.1471-4159.1966.tb09873.x
– volume: 164
  start-page: 1711
  issn: 0007-1188
  issue: 6
  year: 2011
  ident: 58_39966655
  publication-title: British journal of pharmacology
  doi: 10.1111/j.1476-5381.2011.01489.x
– volume: 502
  start-page: 472
  issn: 0028-0836
  year: 2013
  ident: 34_47362447
  publication-title: Nature
  doi: 10.1038/nature12750
– volume: 17
  start-page: 584
  issn: 1359-4184
  issue: 6
  year: 2012
  ident: 6_40716573
  publication-title: Molecular psychiatry
  doi: 10.1038/mp.2011.107
– volume: 145
  start-page: 423
  issn: 0092-8674
  issue: 3
  year: 2011
  ident: 26_39742981
  publication-title: Cell
  doi: 10.1016/j.cell.2011.03.022
– volume: 3
  start-page: 107
  issn: 1946-6234
  year: 2011
  ident: 37_42560642
  publication-title: Science Translational Medicine
– volume: 73
  start-page: 309
  issn: 0306-5251
  issue: 2
  year: 2012
  ident: 53_41090780
  publication-title: British journal of clinical pharmacology
  doi: 10.1111/j.1365-2125.2011.04100.x
– reference: 15655562 - Mol Psychiatry. 2005 Apr;10(4):345-52
– reference: 8143791 - Exp Cell Res. 1994 Apr;211(2):420-3
– reference: 10545613 - Hum Mol Genet. 1999 Nov;8(12):2317-23
– reference: 23908608 - Front Integr Neurosci. 2013 Jul 29;7:55
– reference: 667927 - Cell. 1978 May;14(1):105-13
– reference: 16242410 - Neuron. 2005 Oct 20;48(2):303-14
– reference: 23652932 - Transl Psychiatry. 2013;3:e255
– reference: 23469282 - PLoS One. 2013;8(3):e58473
– reference: 5950056 - J Neurochem. 1966 Aug;13(8):655-69
– reference: 21868513 - Anticancer Res. 2011 Sep;31(9):2723-32
– reference: 20683471 - Nat Rev Mol Cell Biol. 2010 Sep;11(9):607-20
– reference: 22371047 - Mol Psychiatry. 2013 May;18(5):582-94
– reference: 23382250 - Proc Natl Acad Sci U S A. 2013 Mar 19;110(12):4804-9
– reference: 12748177 - J Biol Chem. 2003 Jul 25;278(30):27586-92
– reference: 9499396 - Genes Dev. 1998 Mar 1;12(5):599-606
– reference: 19917878 - Mol Pharmacol. 2010 Feb;77(2):126-35
– reference: 24439381 - Cell. 2014 Jan 16;156(1-2):261-76
– reference: 17149751 - J Neurosci Res. 2007 Feb 15;85(3):525-35
– reference: 19372391 - Science. 2009 May 15;324(5929):930-5
– reference: 11522830 - Nucleic Acids Res. 2001 Sep 1;29(17):3603-10
– reference: 11572963 - Proc Natl Acad Sci U S A. 2001 Sep 25;98(20):11024-31
– reference: 1698097 - Biochim Biophys Acta. 1990 Sep 10;1087(1):80-6
– reference: 19759294 - J Neurosci. 2009 Sep 16;29(37):11451-60
– reference: 22023150 - Br J Clin Pharmacol. 2012 Feb;73(2):309-10
– reference: 22863973 - Anticancer Drugs. 2012 Nov;23(10):1054-66
– reference: 21812623 - World J Biol Psychiatry. 2012 Sep;13(6):458-67
– reference: 18849986 - Nat Neurosci. 2008 Nov;11(11):1271-82
– reference: 2419322 - J Biol Chem. 1986 Feb 25;261(6):2786-90
– reference: 24175168 - World J Psychiatry. 2012 Jun 22;2(3):49-57
– reference: 24153300 - Nature. 2013 Oct 24;502(7472):472-9
– reference: 17453016 - Nat Rev Neurosci. 2007 May;8(5):355-67
– reference: 667928 - Cell. 1978 May;14(1):115-21
– reference: 12706951 - Biol Psychiatry. 2003 Apr 15;53(8):649-59
– reference: 12907316 - Neuropharmacology. 2003 Sep;45(4):553-63
– reference: 2416432 - Cancer Res. 1986 Feb;46(2):713-6
– reference: 1382840 - Cancer Res. 1992 Oct 1;52(19):5213-8
– reference: 596982 - Arch Int Pharmacodyn Ther. 1977 Oct;229(2):327-36
– reference: 17291332 - Genome Biol. 2007;8(2):R19
– reference: 21267076 - PLoS One. 2011;6(1):e14524
– reference: 23052292 - Sci Transl Med. 2012 Oct 10;4(155):155ps19
– reference: 14593184 - Science. 2003 Oct 31;302(5646):890-3
– reference: 8279933 - Arch Gen Psychiatry. 1994 Jan;51(1):8-19
– reference: 21585346 - Br J Pharmacol. 2011 Nov;164(6):1711-21
– reference: 21682946 - Int J Neuropsychopharmacol. 2012 Jun;15(5):669-79
– reference: 17726478 - Nat Neurosci. 2007 Sep;10(9):1116-24
– reference: 22025706 - Proc Natl Acad Sci U S A. 2011 Nov 1;108(44):18108-13
– reference: 16500030 - Neuroscience. 2006;139(3):1017-29
– reference: 24050399 - Neuron. 2013 Sep 18;79(6):1086-93
– reference: 18817816 - Behav Brain Res. 2009 Jan 23;196(2):200-6
– reference: 21242991 - Mol Psychiatry. 2012 Feb;17(2):173-84
– reference: 17522015 - Learn Mem. 2007 Apr;14(4):268-76
– reference: 16945350 - Biol Psychiatry. 2007 Jul 1;62(1):55-64
– reference: 16501568 - Nat Neurosci. 2006 Apr;9(4):519-25
– reference: 17012225 - Carcinogenesis. 2007 Mar;28(3):560-71
– reference: 22784618 - BMC Syst Biol. 2011;5 Suppl 3:S12
– reference: 24452011 - Neuropharmacology. 2014 May;80:115-32
– reference: 23319547 - Pharmacol Rev. 2013 Jan;65(1):143-55
– reference: 22768266 - PLoS One. 2012;7(6):e40262
– reference: 18571370 - J Anxiety Disord. 2009 Jan;23(1):38-45
– reference: 18385331 - J Neurosci. 2008 Apr 2;28(14):3729-37
– reference: 21262856 - J Psychopharmacol. 2011 Oct;25(10):1378-87
– reference: 21496894 - Cell. 2011 Apr 29;145(3):423-34
– reference: 22246241 - Int J Oncol. 2012 May;40(5):1533-42
– reference: 21894152 - Mol Psychiatry. 2012 Jun;17(6):584-96
– reference: 19372393 - Science. 2009 May 15;324(5929):929-30
– reference: 22302827 - J Neurosci. 2012 Feb 1;32(5):1884-97
– reference: 23260135 - Cell. 2012 Dec 21;151(7):1417-30
– reference: 25888486 - Int J Neuropsychopharmacol. 2015 Apr;18(6). pii: pyv026. doi: 10.1093/ijnp/pyv026
– reference: 21262472 - Neuron. 2011 Jan 27;69(2):359-72
– reference: 22321459 - Behav Brain Res. 2012 Apr 21;230(1):85-91
– reference: 15925699 - Neurosci Biobehav Rev. 2005;29(4-5):739-59
– reference: 22339643 - Expert Opin Emerg Drugs. 2012 Mar;17(1):105-26
– reference: 18923034 - J Neurosci. 2008 Oct 15;28(42):10576-86
– reference: 22049069 - Sci Transl Med. 2011 Nov 2;3(107):107ra109
– reference: 22681167 - Curr Pharm Des. 2012;18(36):5879-89
SSID ssj0024536
Score 2.4593005
Snippet Background:Epigenetic drugs like sodium butyrate (NaB) show antidepressant-like effects in preclinical studies, but the exact molecular mechanisms of the...
Epigenetic drugs like sodium butyrate (NaB) show antidepressant-like effects in preclinical studies, but the exact molecular mechanisms of the antidepressant...
Background: Epigenetic drugs like sodium butyrate (NaB) show antidepressant-like effects in preclinical studies, but the exact molecular mechanisms of the...
SourceID swepub
pubmedcentral
proquest
pubmed
crossref
oup
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage pyu032
SubjectTerms Animals
Antidepressants
Antidepressive Agents - pharmacology
Brain-derived neurotrophic factor
Brain-Derived Neurotrophic Factor - genetics
Brain-Derived Neurotrophic Factor - metabolism
Butyric Acid - pharmacology
Depressive Disorder - drug therapy
Depressive Disorder - genetics
Depressive Disorder - metabolism
Dioxygenases - metabolism
Disease Models, Animal
DNA methylation
DNA Methylation - drug effects
Epigenetics
Histone Deacetylase Inhibitors - pharmacology
Male
Prefrontal Cortex - drug effects
Prefrontal Cortex - metabolism
Rats
Up-Regulation - drug effects
SummonAdditionalLinks – databaseName: Scholars Portal Journals: Open Access
  dbid: M48
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3fb5RAEN409cUX42_Rqmti7sEUK-wuuzwY05o2F9OaJt4lfSPADim27p0FEvkP_LOdOeBOtLkXQphZcsfM7H4LM98w9jaH0OaQgy9lEeEhVr6RMvUFgM7RaYzNqFD47Gs0ncsvF-pihw3NOPsHWN26taN-UvOb6_e_frafMOA_9mRIB-V3tzxYts0HgXPxHVySNEXomTQb0j0l-jKjwA-k0n2h3j-DR0vTqNztL9T5f_LkiGJ0tSyd3Gf3ejzJDzsHeMB2wD1kk_OOkLrd57NNfVW1zyf8fENV3T5ivw9dXfbJsPiI_dPyCnhHaMwXBf-2sGXzgx81dUuMErys-GBOsJxe4fLUcZxiKLMdxY7PjmcBXrN0rvxpaylLhrpUt13OHT-lJKWKxIg8-ZF1BSfm68dsfnI8-zz1-94Mfq5MUPu47cPohSiNJehCZnlsbBqnlDUFNii0zNIIp9HQKANgFKSIezIit8cpIAtlIZ6wXbdw8IzxyIgoKNAYBQp0EOJIsFJoHUFmilh77N1gliTvicupf8Z10n1AFwnZMOls6KH7DcrLjq_jdrXXaN_tGnuD7ZPBKxNB7PVShEJ57M1ajAFJX1lSB4umSoJIUV4uIvEtOjrCjRyV_XrsaedO69-CGBQxVGA8pkeOtlYgQvCxxJWXK2Jw6iZgYrznpHPJ0ZD-0hWeQaIQ6Ivw-fb_-ILdRXiouhdOe2y3vmngJUKwOnu1Cq8_oMc1HA
  priority: 102
  providerName: Scholars Portal
Title Antidepressant-Like Effect of Sodium Butyrate is Associated with an Increase in TET1 and in 5-Hydroxymethylation Levels in the Bdnf Gene
URI https://www.ncbi.nlm.nih.gov/pubmed/25618518
https://www.proquest.com/docview/3170143235
https://www.proquest.com/docview/1652400080
https://www.proquest.com/docview/1765975901
https://pubmed.ncbi.nlm.nih.gov/PMC4368891
http://kipublications.ki.se/Default.aspx?queryparsed=id:131079937
Volume 18
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Nj9MwELVg98IF8U1gKUZCPaCNSmI7dk5oi7qq0O5SQVfqLUpiRxsWkkKSQ_4BP5uZxGmJQL1YUWZStZ2x8zyeeUPI29T4OjWpcTnPAhhC4SrOY5cZI1NwGqUTLBS-vAqW1_zTRmxswK2yaZXDmtgt1LpMMUY-Y0gczpnPxIftTxe7RuHpqm2hcZccI3UZpnTJzX7DxQWz1UWe63EhbX0ebOJn-bdiO9u2zXvmj95Ioyq3v8DmvzmTI2bR7m10_oDctzCSnvV2f0jumOIRma56Hur2lK73ZVXVKZ3S1Z6hun1Mfp8VdW5zYOGfdS_yW0N7HmNaZvRrqfPmB503dYtEEjSv6GBFoylGbmlcUFhZMKEdxAVdL9Ye3NN4LdxlqzE5BptTt32qHb3A3KQKxQA46VwXGUXC6yfk-nyx_rh0bUsGNxXKq13Y7cGkNUEcciMznqSh0nEYY7KU0V4meRIHsHr6SihjlDAxwJ0EOe1h5ic-z9hTclSUhXlOaKBY4GVgjAwE0vPhSaM5kzIwicpC6ZB3g1mi1PKVY9uM71F_bs4itGHU29ABrxuUtz1Nx__VXoN9D2ucDLaP7Gyuor3vOeTNTgzzEA9X4sKUTRV5gcB0XADgB3RkAPs3rPZ1yLPenXbfBaAnQCdPOUSOHG2ngDzgY0mR33R84NhEQIXwmdPeJUeP2Fu3cGUiAfie-S8O_8aX5B6gQtHHmU7IUf2rMa8AedXJpJteE3I8X1ytvky6-AWMl1zBuP68-QM9rDZr
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1fb9MwELdG9wAviP8EBjMS9AEt6hLbifOA0AqdOtZVFWTS3rIkdkQYpIWkQvkGfBo-I3d10hKB-raXKspdolT3s31n3_2OkJepdlWqU21znnnwEwhbch7bTGs_BdBIlWCh8NnUG5_zDxfiYof8bmthMK2ynRNXE7Wap7hHPmBIHM6Zy8TbxXcbu0bh6WrbQsPA4lTXPyFkK9-cvAf7vnLd41H4bmw3XQXsVEinsiFgAdxpLw649jOepIFUcRBjvo9WTubzJPZgAnClkFpLoWNYsROkZQfwJi7PGLz3BtnlDEKZHtkdjqazjxt2P8GaeibHdrjwm4rAw4AN8i_FYrCol4fM7ayBnbq6v9zbf7M0O1ymq_Xv-A653Tiu9Mgg7S7Z0cU90p8Z5uv6gIabQq7ygPbpbMOJXd8nv46KKm-ybsGW9iS_0tQwJ9N5Rj_NVb78RofLqkbqCpqXtMWNVhT3imlcUJjLMIUexAUNR6ED9xReC3tcK0zHwXbYtUnuoxPMhipRDC4uHaoio0ix_YCcX4u5HpJeMS_0Y0I9yTwnA2NkIPAdF57UijPf93Qis8C3yOvWLFHaMKRjo46vkTmpZxHaMDI2tADnrfLCEIP8X20f7LtdY6-1fdTMH2W0QbtFXqzFMPLxOCcu9HxZRo4nMAEYXP4tOr4HESPWF1vkkYHT-lvA2QVnzZEW8TtAWysg83hXUuSfVwzk2LZABvDOvoFk55Hm1hVc6UhARMHcJ9v_4z65OQ7PJtHkZHr6lNwCn1SYXa490qt-LPUz8Puq5Hkz2Ci5vO7x_Qcs3m7t
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Antidepressant-Like+Effect+of+Sodium+Butyrate+is+Associated+with+an+Increase+in+TET1+and+in+5-Hydroxymethylation+Levels+in+the+Bdnf+Gene&rft.jtitle=The+international+journal+of+neuropsychopharmacology&rft.au=Ya+Bin+Wei&rft.au=Melas%2C+Philippe+A&rft.au=Wegener%2C+Gregers&rft.au=Math%C3%A9%2C+Aleksander+A&rft.date=2015-01-01&rft.pub=Oxford+University+Press&rft.issn=1461-1457&rft.eissn=1469-5111&rft.volume=18&rft.issue=2&rft_id=info:doi/10.1093%2Fijnp%2Fpyu032
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1461-1457&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1461-1457&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1461-1457&client=summon